We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Offing for Ventas Stock This Earnings Season?
Read MoreHide Full Article
Ventas, Inc. (VTR - Free Report) is scheduled to report first-quarter 2025 results on April 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.
In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 81 cents, beating the Zacks Consensus Estimate by a penny. The quarterly results reflected better-than-anticipated revenues. Ventas’ same-store cash net operating income for the total property portfolio increased year over year.
Ventas’ normalized FFO per share surpassed the Zacks Consensus Estimate in three of the trailing four quarters and met in the remaining period, with the average beat being 1.98%. The graph below depicts this surprise history:
In the first quarter, Ventas’ senior housing operating portfolio (SHOP) is likely to have benefited from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is generally higher than the average population. With the segment witnessing positive net move-ins, occupancy is expected to have remained high.
A well-diversified tenant base with long-term leases is expected to have contributed well to stable rental revenue generation, boosting the top line.
However, the outpatient medical and research portfolio segments are likely to be affected during the to-be-reported quarter.
Further, high interest expenses are expected to have cast a pall on the company’s performance to some extent.
VTR’s Q1 Projections
The Zacks Consensus Estimate for first-quarter resident fees and services is pegged at $909 million, suggesting an increase from $813.3 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter triple-net leased properties' rental income is pegged at $157.2 million, suggesting an increase from the $155.4 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $1.30 billion, implying an 8.7% increase from the prior-year quarter’s reported figure.
Ventas’ activities during the soon-to-be-reported quarter were adequate to gain analysts’ confidence. The Zacks Consensus Estimate for first-quarter FFO per share has increased a cent upward to 82 cents over the past week. The figure implies an increase of 5.1% from the year-ago quarter’s reported number.
However, the consensus mark for outpatient medical and research portfolio rental income for the first quarter is pegged at $216.9 million, indicating a decline from $218.9 million reported in the year-ago period.
What Our Quantitative Model Predicts
Our proven model predicts a likely beat in terms of FFO per share for Ventas this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFO beat, which is the case here.
Ventas currently has an Earnings ESP of +0.18% and carries a Zacks Rank of 2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two other stocks from the broader REIT sector — Welltower (WELL - Free Report) and Vornado Realty Trust (VNO - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
Vornado is slated to report quarterly numbers on May 5. VNO has an Earnings ESP of +2.03% and carries a Zacks Rank of 3 presently. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
What's in the Offing for Ventas Stock This Earnings Season?
Ventas, Inc. (VTR - Free Report) is scheduled to report first-quarter 2025 results on April 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.
In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 81 cents, beating the Zacks Consensus Estimate by a penny. The quarterly results reflected better-than-anticipated revenues. Ventas’ same-store cash net operating income for the total property portfolio increased year over year.
Ventas’ normalized FFO per share surpassed the Zacks Consensus Estimate in three of the trailing four quarters and met in the remaining period, with the average beat being 1.98%. The graph below depicts this surprise history:
Ventas, Inc. Price and EPS Surprise
Ventas, Inc. price-eps-surprise | Ventas, Inc. Quote
Factors at Play
In the first quarter, Ventas’ senior housing operating portfolio (SHOP) is likely to have benefited from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is generally higher than the average population. With the segment witnessing positive net move-ins, occupancy is expected to have remained high.
A well-diversified tenant base with long-term leases is expected to have contributed well to stable rental revenue generation, boosting the top line.
However, the outpatient medical and research portfolio segments are likely to be affected during the to-be-reported quarter.
Further, high interest expenses are expected to have cast a pall on the company’s performance to some extent.
VTR’s Q1 Projections
The Zacks Consensus Estimate for first-quarter resident fees and services is pegged at $909 million, suggesting an increase from $813.3 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter triple-net leased properties' rental income is pegged at $157.2 million, suggesting an increase from the $155.4 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $1.30 billion, implying an 8.7% increase from the prior-year quarter’s reported figure.
Ventas’ activities during the soon-to-be-reported quarter were adequate to gain analysts’ confidence. The Zacks Consensus Estimate for first-quarter FFO per share has increased a cent upward to 82 cents over the past week. The figure implies an increase of 5.1% from the year-ago quarter’s reported number.
However, the consensus mark for outpatient medical and research portfolio rental income for the first quarter is pegged at $216.9 million, indicating a decline from $218.9 million reported in the year-ago period.
What Our Quantitative Model Predicts
Our proven model predicts a likely beat in terms of FFO per share for Ventas this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFO beat, which is the case here.
Ventas currently has an Earnings ESP of +0.18% and carries a Zacks Rank of 2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two other stocks from the broader REIT sector — Welltower (WELL - Free Report) and Vornado Realty Trust (VNO - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
WELL, scheduled to report quarterly numbers on April 28, has an Earnings ESP of +1.69% and carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Vornado is slated to report quarterly numbers on May 5. VNO has an Earnings ESP of +2.03% and carries a Zacks Rank of 3 presently. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.